ArticlePloS one2026
Supply of interventional cardiologists and the provision of lower-value Percutaneous Coronary Interventions (PCI).
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous coronary interventions (PCI) can be lifesaving for patients with acute coronary syndromes but of lower value for patients with stable coronary artery disease (CAD). Previous studies suggest that larger provider supply drives higher healthcare utilization. Whether this is true for lower-value PCI is unknown.
objectiveTo examine the association between the regional supply of PCI-performing physicians and PCI use and lower-value use.
designCross-sectional.
setting100% Medicare fee-for-service (FFS) claims and Medicare Advantage encounter data, linked to publicly available sources of population and hospital data.
participantsAll Medicare FFS and MA beneficiaries undergoing PCI at US hospitals, 2019-2021. MEASUREMENTS: Our exposure was the supply of PCI-performing physicians per million population in the hospital-referral-region (HRR). Our primary outcome was lower-value PCI provision defined as the share of all PCIs performed for stable CAD at the hospital-level, unadjusted and with multilevel linear regression adjustment for hospital and regional-population factors. We also examined both PCI use and lower-value use at the regional (HRR) level.
resultsOur final dataset included 1,580 hospitals across 306 HRRs with 5,505 PCI-performing physicians. In our primary, hospital-level analysis, the lower-value PCI provision rate averaged 17.3% among hospitals located in HRRs in the lowest quintile of PCI provider density and 22.6% among hospitals in HRRs in the highest quintile. In our fully adjusted model, hospitals in the highest provider density quintile had a 5.77 percentage point higher lower-value provision rate than those in the lowest quintile (95% CI 3.70, 7.84; p < 0.01). In our HRR-level analysis, both the total number of PCIs/beneficiary and lower-value PCIs/beneficiary rose with increasing regional PCI-provider density.
conclusionsAmong Medicare beneficiaries, the regional supply of PCI providers correlates with PCI overall and lower-value use. These findings support a role for health planning efforts to align workforce supply with community health needs to constrain both costs and the provision of low-value care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.